NEURELIS CEO CRAIG CHAMBLISS TO PRESENT KEYNOTE AT THE 14TH ANNUAL OUTSOURCING IN CLINICAL TRIALS SOUTHERN CALIFORNIA 2026 CONFERENCE ...Middle East

SAN DIEGO, Sept. 10, 2026 /PRNewswire/ -- Neurelis, Inc., the innovator behind VALTOCO® (diazepam nasal spray), today announced its Founder and Chief Executive Officer Craig Chambliss will give a keynote address at the 14th Annual Outsourcing Clinical Trials (OCT) Southern California 2026...

Hence then, the article about neurelis ceo craig chambliss to present keynote at the 14th annual outsourcing in clinical trials southern california 2026 conference was published today ( Thursday 10/09/2026 - 04:02 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( NEURELIS CEO CRAIG CHAMBLISS TO PRESENT KEYNOTE AT THE 14TH ANNUAL OUTSOURCING IN CLINICAL TRIALS SOUTHERN CALIFORNIA 2026 CONFERENCE )

Also on site :

• Kiev plotted terror attack on UK ambassador in Moscow – FSB
• 1980 No. 1 Hit, Featured in Classic John Travolta Movie, Ranked Among ‘Greatest Country Songs of All Time’
• Egypt highlights growing opportunities for fintech investors